JSP invests in new manufacturing facilities for PPE
30 March 2021
INVESTMENT IN new manufacturing facilities has been announced by JSP to increase PPE production capacity in its factories in the UK and Germany.
This investment will further support the growth of JSP's operations in its main international markets in Europe, USA, UAE, Asia Pacific and China.
JSP specialises in head, eye, face, hearing and respiratory protection and has seen a sharp rise in demand for PPE and Respiratory Protective Equipment (RPE) since the start of the Covid-19 pandemic. In response, it has restructured its healthcare division to meet an increasing demand from both new and existing UK and international customers and has played a key role, along with its distribution partners, in supplying products to more than 120 NHS Trusts in England.
New investment will include large scale automated production lines capable of mass production of RPE (Respiratory Protective Equipment). These will support the growing demand for disposable and reusable masks, as well as Powered Air Purifying Respirators (PAPR), protective eyewear and face-shields.
Further investment has been made with additional ISO9001 BSI approved test-houses in each manufacturing facility together with Quality Assurance Laboratories and a new team of research and development engineers for future product innovation and development.
Mark Johnstone, CEO at JSP, says: “We are pleased to have been able to support our customers by supplying them with highest quality JSP products during this unprecedented period. The additional investment not only allows us to continue to invest in new technology, as well as increase our production capabilities, but also to create new employment opportunities, support our business and meet growing customer demand.
JSP will officially open these new production facilities in the UK and Germany as early as April to strengthen capacity to guarantee a sustainable supply of large volumes of respiratory masks and other requirements of PPE in the UK and Internationally for frontline workers in healthcare and the NHS, and other key workers.